$SLXN +132% Premarket 🚀 🔹 Massive move as Silexion Therapeutics catches fire on renewed attention around SIL204, its RNAi-based cancer therapy platform 📈 🔹

$SLXN +132% Premarket 🚀 🔹 Massive move as Silexion Therapeutics catches fire on renewed attention around SIL204, its RNAi-based cancer therapy platform 📈 🔹 Company is targeting KRAS-driven cancers, including pancreatic cancer — one of the toughest areas in oncology 🎯 🔹 Recent preclinical data …